Novo Nordisk A/S ADR (NYSE:NVO) - Overview

Stock Report

Novo Nordisk A/S NVO

Last Price
$33.93

Day Change
0.38|1.13%

As of 02/12/2016
17:44:40 EST | USD
Minimum 15 Minutes Delay.

Last Close33.55
Day Range33.67 - 34.00
Mkt Cap88.22Bil
52-Wk Range30.89 - 59.00
Yield %4.16
ISINUS6701002056
Volume3,790,173
P/E-
P/S5.42
P/CF12.74

Share Price

Financials
201320142015
More ...
Income Statement
Revenue83,572.0088,806.00107,927.00
Operating Income31,493.0034,492.0049,444.00
Net Income25,184.0026,481.0034,860.00
Basic EPS9.4010.1013.56
Avg. Diluted Shares Outstanding2,6942,6302,578
Balance Sheet
Current Assets42,058.0046,293.0055,140.00
Non Current Assets28,279.0030,769.0036,659.00
Total Assets70,337.0077,062.0091,799.00
Current Liabilities24,225.0033,689.0040,873.00
Total Liabilities27,768.0036,768.0044,830.00
Total Equity42,569.0040,294.0046,969.00
Cash Flow
Operating Cash Flow25,942.0031,692.0038,287.00
Capital Expenditure-3,644.00-4,335.00-6,406.00
Free Cash Flow22,298.0027,357.0031,881.00

In millions, except "Basic EPS". Currency is DKK.

Company Profile

Novo Nordisk A/S is a healthcare company that is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company has two business segments: diabetes & obesity care and biopharmaceuticals.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

42,600
Key Stats
More ...
Price/Earning TTM-
Price/Book14.73
Price/Sales TTM-
Rev Growth (3 year avg)11.42
EPS Growth (3 year avg)-
Operating Margin % TTM45.81
Net Margin % TTM32.30
ROE TTM79.90
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Date12/02/1605/08/16
Ex-Div18/03/1611/08/16
Paid30/03/1623/08/16
Amnt0.960.45
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.